Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023

Brian Cheng Maintained (ZYME) at Hold with Increased Target to $9 on, Mar 31st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-9-on-mar-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Cheng of JP Morgan, Maintained "Zymeworks Inc." (ZYME) at Hold with Increased Target from $8 to $9 on, Mar 31st, 2023.

Brian has made no other calls on ZYME in the last 4 months.



There are 7 other peers that have a rating on ZYME. Out of the 7 peers that are also analyzing ZYME, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robert Burns of "HC Wainwright & Co." Reiterated at Hold and Held Target at $8 on, Tuesday, March 21st, 2023
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022


These are the ratings of the 4 analyists that currently disagree with Brian


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $12 on, Tuesday, March 21st, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 10th, 2023
  • Charles Zhou of "Guggenheim" Reiterated at Strong Buy and Held Target at $16 on, Wednesday, March 8th, 2023
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022

Publication Contributing Sources